New: Vitaphone remosECG 100/300 BT Optimises Telecardiological Diagnostics
Mannheim. “ECG to go“, the recording of ECGs always and everywhere – this is the solution to find out about the causes for millions of persons suffering from sporadically occurring cardiac arrhythmia that often are a high strain. But: Only some clinics and cardiologists offer this modern possibility of telecardiological function diagnostics by means of the tele ECG. This is even more surprising as the number of persons affected increases drastically every year on account of the demographic development alone. Moreover: Cardiac arrhythmia may be a sign of life-threatening diseases - for example atrial fibrillation, that may result in an apoplectic stroke if it is not treated. With remosEKG 100/300 BT, Vitaphone GmbH, the globally acting and internationally leading provider of telemedical devices and services, presents another innovative tool for telemedical diagnostics of symptomatic cardiac arrhythmia on the occasion of the MEDICA 2009 in Düsseldorf.
The patients who wear remosEKG 100/300 BT around their neck are able to record an ECG always and everywhere in their everyday life - without any cables thanks to integrated electrodes. Simply, at the touch of a button and always when they have a feeling that their heart gets out of step. Then, the device transmits the ECG data to Vitaphone GmbH’s Telemedical Service Center via bluetooth and mobile phone. All this takes place completely automatically. The ECG data can also be transmitted via a landline telephone. The ECG is made available to the attending physicians for evaluation in clinic or practice immediately after transmission. Either by fax, by e-mail or on a dedicated server in the Internet. Alternatively, the stored ECG data can also be read directly into the PC in the clinic or medical practice by means of special software - the remosManager.
The device remosEKG 100/ 300 BT is available as 1- or 3-channel ECG. Up to 120 ECGs can be recorded – depending on the presetting of a duration of 40 to 300 seconds. “We have developed the remosEKG 100/300 BT on account of the demand of a large number of customers abroad. Especially overseas, there are many countries whose landline telephony is hardly developed and where communication mainly takes place via mobile phone. This innovation in the field of telecardiological function diagnostics bridges a real gap in the market and gives us another unique feature worldwide for our devices and services," explains Dipl.-Kaufmann Matthias Quinger, managing partner of Vitaphone GmbH.
Professor Dr. med. Hans-Joachim Trappe, Director of Med. Univ.-Klinik II Marienhospital Herne/Ruhr-Universität Bochum: “As I see it, the tele ECG is the device of first choice for the close monitoring of patients and the reliable diagnosis of symptomatic cardiac arrhythmia. Our experience is absolutely positive and I always wonder why this possibility of simple and precise telecardiological function diagnostics is that less used and offered in clinics and medical practices".
Background information on cardiac arrhythmia
On account of the demographic development, cardiac arrhythmia is a globally increasing problem. According to estimates made by experts, 5.5 million people suffer from atrial fibrillation alone. Therefore, atrial fibrillation is the most frequent type of cardiac arrhythmia. Patients with atrial arrhythmia have a five time higher risk of sustaining an apoplectic stroke - with the well-known individual and economic consequences. The diseases associated with atrial fibrillation include cardiac insufficiency and sudden cardiac arrest that accounts for up to 20 percent of all cases of cardiac death and is caused by tachycardiac arrhythmia in most cases. Therefore, the early identification of risk patients is particularly important in cardiological clinic and practice. Telecardiological function diagnostics make a valuable contribution in this context.